PureVision
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $14M
Investors
- 6
About PureVision
, doing business as PureVision, is a medical technology company that provides glaucoma treatment stent products. The company was founded by Dr.D. The company's main product is AqueFish™, a stent product for closed-angle and open-angle glaucoma. The company generates revenue from developing ophthalmic medical devices and solutions.
Who invested in PureVision
6 investors across 2 rounds
See all investors in PureVision
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PureVision
Who invested in PureVision?
PureVision has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PureVision raised?
PureVision has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PureVision last raise money?
PureVision's most recent round on record is a Series A, in Jan 2026.
What does PureVision do?
, doing business as PureVision, is a medical technology company that provides glaucoma treatment stent products.
Where is PureVision headquartered?
PureVision is headquartered in Guangzhou, China.
Which VCs invest in companies like PureVision?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at PureVision's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like PureVision? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.